Thus, gene regulatory networks highlighted by this unbiased, cross species analysis appeared to recapitulate some key features of AD progression and support a key driver role for TREM2/TYROBP in AD pathogenesis. This evidence concerns the gene TREM2 and Alzheimer disease.